1361033-90-0

Basic information

• Product Name: N-([1,1'-diphenyl]-4-ylmethyl)-N-(phenylsulfonyl)benzenesulfonamide
• Synonyms: N-([1,1'-diphenyl]-4-ylmethyl)-N-(phenylsulfonyl)benzenesulfonamide
• CAS NO: 1361033-90-0
• Molecular Weight: 463.578
• Mol File: 1361033-90-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-([1,1'-diphenyl]-4-ylmethyl)-N-(phenylsulfonyl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-([1,1'-diphenyl]-4-ylmethyl)-N-(phenylsulfonyl)benzenesulfonamide(1361033-90-0)
• EPA Substance Registry System: N-([1,1'-diphenyl]-4-ylmethyl)-N-(phenylsulfonyl)benzenesulfonamide(1361033-90-0)

Safety Data

• Hazardous Substances Data: 1361033-90-0(Hazardous Substances Data)

Upstream product

• 5728-52-9 (4-biphenylyl)acetic acid 
• 2618-96-4 dibenzenesulfonamide 
• 644-08-6 4-Methylbiphenyl 
• 133745-75-2 N-fluorobis(benzenesulfon)imide 

Relevant articles and documents

Ligand-free iron-catalyzed benzylic C (sp3)-H amination of methylarenes with: N -fluorobenzenesulfonimide

Direct conversion of cheap methylarenes to benzylic amines, which are essential structural units of important drugs, is of great significance. However, the known methodologies suffer from the requirement of noble metal catalysts, heavy metal residues or s

Late-Stage Functionalization of Arylacetic Acids by Photoredox-Catalyzed Decarboxylative Carbon–Heteroatom Bond Formation

The rapid transformation of pharmaceuticals and agrochemicals enables access to unexplored chemical space and thus has accelerated the discovery of novel bioactive molecules. Because arylacetic acids are regarded as key structures in bioactive compounds, new transformations of these structures could contribute to drug/agrochemical discovery and chemical biology. This work reports carbon–nitrogen and carbon–oxygen bond formation through the photoredox-catalyzed decarboxylation of arylacetic acids. The reaction shows good functional group compatibility without pre-activation of the nitrogen- or oxygen-based coupling partners. Under similar reaction conditions, carbon–chlorine bond formation was also feasible. This efficient derivatization of arylacetic acids makes it possible to synthesize pharmaceutical analogues and bioconjugates of pharmaceuticals and natural products.